TLS:NASDAQTelos Corporation Analysis
Data as of 2026-05-27 - not real-time
$4.69
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Telos Corp (TLS) posted a 55.9% YoY revenue surge to $181.9M, beating estimates and driving an increasing volume trend. The Q1 earnings beat consensus, delivering $0.06 EPS versus a loss a year ago, and management highlighted strategic share repurchases despite recent leadership changes. Technicals show a bullish MACD (0.076 above signal) and an RSI of ~60, keeping momentum neutral‑to‑positive, while the price sits near the $4.88 resistance above the $4.05 support. The stock trades at a forward P/E of 18, well below the software‑infrastructure industry average of 40.6, and the DCF model assigns a fair value of $12.46, implying a ~45% upside.
However, the company still reports a ‑14% profit margin, negative EBITDA and a high debt‑to‑equity of 7.8, which together with a beta of 1.94 and 30‑day volatility of 51% raise the risk profile. The lack of dividend and modest cash balance of $50.2M relative to debt further constrain defensive appeal. Given the strong top‑line growth, attractive valuation multiples and bullish technical signals, the stock presents a high‑conviction upside play, albeit with heightened volatility and leverage concerns.
However, the company still reports a ‑14% profit margin, negative EBITDA and a high debt‑to‑equity of 7.8, which together with a beta of 1.94 and 30‑day volatility of 51% raise the risk profile. The lack of dividend and modest cash balance of $50.2M relative to debt further constrain defensive appeal. Given the strong top‑line growth, attractive valuation multiples and bullish technical signals, the stock presents a high‑conviction upside play, albeit with heightened volatility and leverage concerns.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Bullish MACD and rising volume support near‑term price stability
- Price near resistance at $4.88 with support at $4.05
- Recent earnings beat and strong revenue growth
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF fair value indicates ~45% upside
- Forward P/E of 18 versus industry average of 40
- Continued top‑line momentum and strategic share repurchases
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High beta (1.94) and 30‑day volatility of 51% increase market risk
- Elevated debt‑to‑equity ratio (7.8) raises leverage concerns
- Secular demand for cyber and identity security solutions
Key Metrics & Analysis
Financial Health
Revenue Growth55.90%
Profit Margin-14.25%
P/E Ratio18.0
ROE-23.28%
ROA-5.87%
Debt/Equity7.80
P/B Ratio3.6
Op. Cash Flow$32.7M
Free Cash Flow$25.0M
Industry P/E40.6
Technical Analysis
TrendNeutral
RSI59.9
Support$4.05
Resistance$4.88
MA 20$4.40
MA 50$4.32
MA 200$5.41
MACDBullish
VolumeIncreasing
Fear & Greed Index91.05
Valuation
Fair Value$12.46
Target Price$6.83
Upside/Downside45.70%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.94
Volatility51.12%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.